GlassScriptPhysician profile
Scott Alan Silverberg
NPI 1396832911
$877.34
in general payments reported to CMS, 2019-2025
13 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $44.69 · 2022: $113 · 2023: $262 · 2024: $165 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $339.92 | 2019-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $91.51 | 2024-2025 | |
| Bioventus LLC | $77.79 | 2019-2024 | Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Linvatec Corporation | $72.44 | 2022 | |
| Axogen | $48.42 | 2019 | |
| Smith+Nephew, INC. | $44.48 | 2019-2020 | |
| Stryker Corporation | $43.18 | 2023 | Omega |
| Baxter Healthcare | $39.13 | 2023 | Actifuse |
| Sanofi-Aventis U.S. LLC | $29.56 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $24.88 | 2025 | Exparel |
| Djo, LLC | $23.34 | 2019 | |
| Depuy Synthes Sales INC. | $22.52 | 2025 | Monovisc, Orthovisc |
| Lilly USA, LLC | $20.17 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Silverberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.